Almagul Kushugulova
Nazarbayev University, Astana, Kazakhstan
Title: The beneficial properties of a new synbiotic yoghurt “NAR†(ÐӘР)
Biography
Biography: Almagul Kushugulova
Abstract
Recent studies have shown that probiotic yoghurt consumption may have a positive role in the regulation of body weight as well as act to prevent cardiovascular diseases. Dairy products are a source of high quality protein, and due to the functional properties of live bacteria, yoghurt have unique properties. Objective is to test the efficacy of new a synbiotic formulation in adults with metabolic syndrome.
This randomized double-blind placebo controlled trial was conducted among 180 participants aged 25 to 75 years. Subjects with and without metabolic syndrome were randomly assigned to receive synbiotic or placebo daily for three months.
134 of 180 participants completed the study. Compared with the placebo group, the synbiotic group had significantly decreased total cholesterol.
Our study is the first large clinical trial of probiotics in Kazakhstan and the first study on the new synbiotic yoghurt NAR. The uniqueness of this product lies in the fact that it consists of probiotic component strains isolated from a traditional Kazakh koumiss product. Primarily, the product is aimed at people with digestive problems. Therefore, it is rich in easily digestible trace elements and amino acids, essential for the gut microbiota to flourish. We adhered to best practices for clinical trials to ensure that both investigators and patients were blinded to the study and that the data analysis was carried out by independent statisticians.
The present findings suggest positive influence of synbiotic on controlling excess weight and treating some metabolic disorders in adults.